Health ❯ Healthcare ❯ Medical Research

Dementia

Alzheimer's Disease Biomarkers Urine Protein Testing GLP-1 Drugs Infection and Dementia Risk Predictive Testing Survival Rates Drug Repurposing

Blood Studies Point to Complementary Alzheimer’s Biomarkers for Prediction and Staging

Evidence points to distinct uses for blood tests in prognosis versus staging.

Blood Test Using p‑Tau217 Predicts Dementia Risk in Women Up to 25 Years Before Symptoms

Exeter-Led Review Flags Shingles Vaccine, Riluzole and Viagra for Alzheimer’s Trials

Urine Protein Test Flags Higher Dementia Risk in Large Swedish Study

FDA Approves 95% Sensitive Blood Test for Alzheimer’s

Blood Test Advances Alzheimer’s Diagnosis and Staging with 92% Accuracy

Study Links Common Medications to Reduced Dementia Risk

Study Reveals Life Expectancy After Dementia Diagnosis Varies by Age and Type